Search / Trial NCT06230133

Feasibility and the Effects of Mindfulness-Based Stress Reduction (MBSR) on College Students

Launched by ARMY MEDICAL UNIVERSITY, CHINA · Jan 19, 2024

Trial Information

Current as of October 09, 2024

Completed

Keywords

Military Medical Students, Mindfulness, Resilience

Description

Recruitment for the study was done via broadcast email and posted notices online. 372 students filled out screening questionnaires and indicated their intention to participate the Mindfulness Based Stress Reduction (MBSR) course. We selected 120 students according to the participant criteria. Of the 120 participants, 60 were randomly assigned to the MBSR or control groups. However, 8 participants were absent more than two courses in the MBSR group, and 24 participants did not complete the post-test. Eventually, we enrolled 52 participants in the intervention group and 36 participants in the...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * No regular meditation and yoga practice within the past 6 months;
  • * No current psychiatric symptoms and physical contraindications to exercise;
  • * the resilience scale scores were in the last 27% of the total 372 students.
  • Exclusion Criteria:
  • * Unwillingness to participant the mindfulness class;
  • * Absence from 2 or more classes;
  • * Do not complete the pre-, post-test and follow-up psychological assessment.

About Army Medical University, China

Army Medical University, located in China, is a leading institution dedicated to advancing military and civilian healthcare through innovative research and education. Renowned for its commitment to medical excellence, the university plays a pivotal role in conducting clinical trials aimed at addressing critical health challenges faced by both military personnel and the general population. With a strong emphasis on translational medicine, Army Medical University integrates cutting-edge scientific research with clinical applications, fostering collaborations that enhance treatment strategies and improve patient outcomes. The institution adheres to rigorous ethical standards and regulatory compliance, ensuring the integrity and reliability of its clinical trial initiatives.

Locations

Chongqing, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0